The Epstein-Barr virus infects more than 90 percent of people in the United States by the age of 20. At least one in four of those infected will develop
the commonly-known disease mononucleosis, or “mono,” experiencing a rash, enlarged liver or spleen, head- and body aches, and extreme fatigue.
However, Epstein-Barr virus (EBV) is not only related to mono. Recent studies indicate it may be a catalyst for at least six more diseases, most of which are autoimmune in nature. These include multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis, celiac disease, Type 1 diabetes, and juvenile idiopathic arthritis.